Corbin Therapeutics

About:

Corbin Therapeutics is a biotechnology platform develops drugs from ubiquitin carboxyl-terminal hydrolase.

Description:

Corbin Therapeutics is a provider of a drug discovery platform. The company's biotechnology platform develops drugs from ubiquitin carboxyl-terminal hydrolase 15 (USP15) enzyme to treat various inflammation-based diseases.

Total Funding Amount:

1M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montreal, Quebec, Canada

Founded Date:

2016-01-01

Contact Email:

info(AT)corbinthera.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2017-01-11

IPO Status:

Private

Industries: